| Literature DB >> 27747796 |
Jason C Siegler1, Paul W M Marshall2, David Bishop3, Greg Shaw4, Simon Green2,5.
Abstract
A large proportion of empirical research and reviews investigating the ergogenic potential of sodium bicarbonate (NaHCO3) supplementation have focused predominately on performance outcomes and only speculate about underlying mechanisms responsible for any benefit. The aim of this review was to critically evaluate the influence of NaHCO3 supplementation on mechanisms associated with skeletal muscle fatigue as it translates directly to exercise performance. Mechanistic links between skeletal muscle fatigue, proton accumulation (or metabolic acidosis) and NaHCO3 supplementation have been identified to provide a more targeted, evidence-based approach to direct future research, as well as provide practitioners with a contemporary perspective on the potential applications and limitations of this supplement. The mechanisms identified have been broadly categorised under the sections 'Whole-body Metabolism', 'Muscle Physiology' and 'Motor Pathways', and when possible, the performance outcomes of these studies contextualized within an integrative framework of whole-body exercise where other factors such as task demand (e.g. large vs. small muscle groups), cardio-pulmonary and neural control mechanisms may outweigh any localised influence of NaHCO3. Finally, the 'Performance Applications' section provides further interpretation for the practitioner founded on the mechanistic evidence provided in this review and other relevant, applied NaHCO3 performance-related studies.Entities:
Year: 2016 PMID: 27747796 PMCID: PMC5059234 DOI: 10.1186/s40798-016-0065-9
Source DB: PubMed Journal: Sports Med Open ISSN: 2198-9761
Fig. 1Resting changes in blood bicarbonate [HCO3 −] and pH after ingesting 0.2 and 0.3 g·kg−1 of sodium bicarbonate (NaHCO3) (reproduced from Siegler et al. [3] with permission)
A summary of studies conducted in the mid 1980’s that reported an ergogenic effect of 0.3 g kg−1 sodium bicarbonate (NaHCO3) supplementation on performance tasks lasting approximately −7 min
| Study | Subject characteristics | Task | Control | NaHCO3 | Improvement (%) |
|---|---|---|---|---|---|
| Wilkes et al. ‘83 [ | University track athletes | 800-m foot race | 2:05.8 ± 2.1 (min:s) | 2:02.9 ± 1.9 (min:s) | ~2 % |
| Costill et al. ‘84 [ | VO2max: 4.8 L min−1 (3.12–6.33) | 5, 1-min cycling bouts (125 % VO2max; 5th bout to exhaustion) | 113.5 ± 12.4 s | 160.8 ± 19.1 s | ~42 % |
| McKenzie et al. ‘86 [ | VO2max: 3.83 ± 0.61 L min−1 | 6, 60-s cycling bouts (125 % VO2max; 6th bout to exhaustion) | 74.7 ± 17.6 s | 106 ± 6.9 s | ~30 % |
| Gao et al. ‘86 [ | Well-trained college swimmers (VO2max: 4.3 ± 0.1 L min−1) | 5, 100-yd freestyle swim | 4th bout: ~1.65 m s−1
| 4th bout: ~1.62 m s−1
| ~2 % |
| Goldfinch et al. ‘88 [ | Male athletes | 400-m foot race | 58.46 ± 2.49 s | 56.94 ± 2.25 s | ~3 % |
Subject characteristics are represented to the level of detail provided in the original published studies. All values in the (%) improvement column were significantly different from control (p < 0.05)
Fig. 2Overview of the mechanisms associated with sodium bicarbonate supplementation (NaHCO3) and whole-body metabolism, muscle physiology and motor pathways. Definitions for the following abbreviations are provided for mH+ (muscle protons), mLa− (muscle lactate), MCT (monocarboxylate transporters), bLa− (blood lactate) and [PCr]/[Pi] (ratio of phosphocreatine to inorganic phosphate)
A summary of the results of studies investigating the influence of 0.3 g kg−1 sodium bicarbonate (NaHCO3) supplementation on whole-body and isolated muscle incremental exercise to volitional exhaustion
| Study | Whole-body or isolated muscle | Incremental task | Performance effect |
|---|---|---|---|
| Raymer et al. ‘04 [ | Isolated (forearm) | 1:1 contraction-relaxation cycle; initial resistance 1.0 kg then increased 0.22 kg min−1 | ~12 % improvement |
| Sostaric et al. ‘05 [ | Isolated (concentric finger flexion) | 30 rep min−1; initial resistance 2.6 ± 0.22 W then increased 0.17 W min−1 | ~25 % improvement |
| Poulus et al. ‘74 [ | Whole-body (cycling) | Fixed cadence with 10 W min−1 increased until volitional exhaustion) | No effect |
| Jones et al. ‘77 [ | Whole-body (cycling) | 20 min at power output ~33 % VO2max, then 20 min at 66 % VO2max, then 95 % VO2max to volitional exhaustion | ~40 % improvement |
| Sutton et al. ‘81 [ | Whole-body (cycling) | 20 min at power output ~33 % VO2max, then 20 min at 66 % VO2max, then 95 % VO2max to volitional exhaustion | ~30 % improvement |
| Kowalchuk et al. ‘84 [ | Whole-body (cycling) | Increased 16 W min−1 at 60 rpm | No effect |
| Housh et al. ‘91 [ | Whole-body (cycling) | Continuous (2-min stages) physical work capacity test (PWCFT) starting at 60 W to volitional exhaustion | No effect |
All values represented as having an improvement (%) were significantly different from control or placebo (p < 0.05)